JPMorgan’s strategic situations division led a $30 million revolving credit facility and a new $370 million first lien term loan for Healogics, a provider of wound care. Healogics also secured $240 million in equity investments.
Alvarez & Marsal appointed John P. Malfettone senior advisor with the firm’s global transaction advisory group. He previously served at Clayton Dubilier & Rice as a senior managing director and head of operations, among other roles.
Private equity group Clayton, Dubilier & Rice had made an offer to acquire healthcare communications business Huntsworth for £400 million ($511 million).
Clayton, Dubilier & Rice appointed John Dineen as an operating advisor to CD&R’s funds, effective early next year. Dineen is a 28-year veteran of General Electric. Most recently, he served as CEO of GE Healthcare.
Clayton, Dubilier & Rice announced an agreement under which CD&R-managed funds will acquire Healogics Holding. J.P. Morgan Securities, Credit Suisse, BofA Merrill Lynch, Citigroup Global Markets and Morgan Stanley have committed debt financing for the transaction.